enGene Holdings Inc.
ENGN · NASDAQ
10/31/2025 | 10/31/2024 | 10/31/2023 | 10/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $1 | $0 | $0 | $0 |
| Gross Profit | -$1 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $94 | $38 | $16 | $15 |
| G&A Expenses | $29 | $24 | $0 | $3 |
| SG&A Expenses | $29 | $24 | $9 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $1 |
| Operating Expenses | $123 | $62 | $26 | $19 |
| Operating Income | -$123 | $62 | -$26 | -$2 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $6 | -$7 | -$74 | $2 |
| Pre-Tax Income | -$117 | $55 | -$100 | $0 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | $117 | -$55 | -$100 | $0 |
| % Margin | – | – | – | – |
| EPS | -2.29 | -1.46 | -4.24 | 0.002 |
| % Growth | -56.8% | 65.6% | -223,257.9% | – |
| EPS Diluted | -2.29 | -1.46 | -4.24 | 0.002 |
| Weighted Avg Shares Out | 51 | 45 | 24 | 16 |
| Weighted Avg Shares Out Dil | 51 | 45 | 24 | 16 |
| Supplemental Information | – | – | – | – |
| Interest Income | $9 | $10 | $1 | $0 |
| Interest Expense | $3 | $3 | $5 | $1 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | -$114 | -$52 | -$95 | $0 |
| % Margin | – | – | – | – |